Showing results (91-100 of 268) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Intraperitoneal cytosine arabinoside therapy in ovarian carcinomaM E King, C E Pfeifle, S B HowellArthritis and Rheumatism|April 1, 1984
Work disability before and after total hip arthroplasty. Assessment of effectiveness in reducing disabilityM C Nevitt, W V Epstein, M Masem, et al.Arthritis and Rheumatism|March 1, 1981
The impact of chronic disease: a sociomedical profile of rheumatoid arthritisR F Meenan, E H Yelin, M Nevitt, et al.Cancer Communications|January 1, 1990
The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cellsE J Katz, P A Andrews, S B HowellEuropean Journal of Cancer & Clinical Oncology|April 1, 1989
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cellsP A Andrews, M P Murphy, S B HowellMolecular Pharmacology|August 27, 1999
Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatinE D Scheeff, J M Briggs, S B HowellMedical and Pediatric Oncology|January 1, 1982
Modulation of the cellular pharmacology and clinical toxicity of 1-beta-D-arabinofuranosylcytosineS B Howell, J A Streifel, C E PfeifleInternational Journal of Cancer|July 30, 1991
Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B HowellCancer|July 1, 1986
Cisplatin administered by the intracavitary route as treatment for malignant mesotheliomaM Markman, S Cleary, C Pfeifle, et al.Clinical Pharmacology and Therapeutics|November 1, 1979
Effect of probenecid on cerebrospinal fluid methotrexate kineticsS B Howell, R A Olshen, J A RicePageof 27